I’m debating whether to sell my UNH stock now or wait until after the earnings report. If it’s going to tank next week, I’d rather sell it now and be done with it.
8 replies (most recent on top)
If you sale it should be after the earning report. It will go up and than sale before it tanks again.
Optum not being able to upcode, and UHC loosing big markets, not sure the long term prospects. It is only matter of time when the orange man says - single payer system, sc--w all insurance. I guess Optum still has clinics regardless of who the payer is. Maybe it won’t go to zero that quick.
Sold my stock last year... money better used elsewhere.
@OP I am too I’d rather go out a tad higher than stay with til the bottom falls out
They will beat but Wall st is wise to unh cr-p. They cannot cut their way to a meaningful rise in share price. Any regulatory overhang keep a lid on it. It's just a value trap and most thinking it has to get some of that 600 share price back, right? Most just looking for a return to 440 or so before dumping it.
@OP probably a non-event. I’m sure they deferred as much revenue into 2026 as possible and dumped as many expenses in 2025 as possible to maintain the $2 eps for the last Q of 2025.
Will say something about the turnaround is ongoing and will report an earnings projection for 2026 at the next release in April.
@a9 long-term I’m not sure what to think, but I’ve decided not to keep any individual stocks anymore and only invest in index funds. I’ve already sold my ESPP stocks, but I have some others that I bought last year when it was lower.
I’m deciding whether to sell them now, or to sell after the earnings report. Either way I’m not keeping long term.
@OP Do you believe in the company’s prospects long term? It doesn’t sound like it so maybe take the 10%+ return from this last ESPP lot and sell beforehand. I know this isn’t the best place to work but I think there’s a good chance UNH stockholders outperform this year. Who knows if that move will start after next week’s earnings.